NC
ACHV icon

nVerses Capital’s Achieve Life Sciences ACHV Stock Holding History

nVerses Capital’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Buy
18,201
+4,006
+28% +$19.1K 0.18% 235
2026
Q1 		$41.7K Buy
+14,195
New +$63K 0.04% 342

Other funds holding ACHV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

nVerses Capital's ACHV Position: Q2 2026 in Review

nVerses Capital increased its Achieve Life Sciences (ACHV) stake by 28% in Q2 2026, buying an estimated $19.1K and bringing the position to 18,201 shares worth $119K. The position accounts for 0.18% of the portfolio, ranked #235.

nVerses Capital first reported a position in ACHV in Q1 2026 and has held it in 2 quarters since. 69 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • nVerses Capital held 18,201 shares of Achieve Life Sciences worth $119K as of Q2 2026.
  • nVerses Capital bought 4,006 Achieve Life Sciences shares in Q2 2026, an estimated $19.1K.
  • Achieve Life Sciences made up 0.18% of nVerses Capital's portfolio in Q2 2026, its #235 holding.
  • nVerses Capital first reported a position in Achieve Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 69 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.